The Molecular Genetics of Wilms Tumor: A Paradigm of Heterogeneity in Tumor Development

References

• Breslow NE, Beckwith JB. Epidemiological features of Wilms' tumor: Results of the National Wilms' Tumor Study. J Natl Cancer Inst 1982; 68: 429–436
   PubMed Web of Science ®Google Scholar
• Breslow NE, Beckwith JB, Ciol M. Age distribution of Wilms' tumor: Report from the National Wilms' Tumor Study. Cancer Res 1988; 48: 1653–1657
   PubMed Web of Science ®Google Scholar
• Miller RW, Fraumeni JF, Manning MD. Association of Wilms' tumor with aniridia, hemihypertrophy and other congenital malformations. N Engl J Med 1964; 270: 922–927
   PubMed Web of Science ®Google Scholar
• Wiedemann HR. Complese malformatif familial avec hernie ombilicale et macroglossie—Un “syndrome nouveau”. J Genet Hum 1964; 13: 223–232
   PubMedGoogle Scholar
• Beckwith JB. Macroglossia, omphalocele, adrenal cytomegaly, gigantism and hyperplastic visceromegaly. Birth Defects 1969; 5: 188–196
   Google Scholar
• Sotelo-Avila C, Gooch WM. Neoplasms associated with the Beckwith-Wiedemann syndrome. Perspect Pediatr Pathol 1976; 3: 255–272
   PubMedGoogle Scholar
• Denys P, Malvaux P, VanDenBerghe H. Association d'un syndrom anatomopathologique: De pseudohermaphrodisme masculin, d'une tumeur de Wilms, d'une nephropathie parenchymateuse et d'masaicisme XX/XY. Arch Franc Pediatr 1967; 24: 729–739
   PubMedGoogle Scholar
• Drash A, Sherman F, Hartmann WH. A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension and degenerative renal disease. J Pediatr 1971; 76: 585–593
   Web of Science ®Google Scholar
• Perlman M, Goldberg GM, Bar Ziv J. Renal hamartomas and nephroblastomatosis with fetal gigantism: A familial syndrome. J Pediatr 1973; 83: 414–418
   PubMed Web of Science ®Google Scholar
• Mankad VN, Gray GF, Miller D. Bilateral nephroblastomatosis and Klippel-Trenaunay syndrome. Cancer 1974; 33: 1462–1467
   PubMed Web of Science ®Google Scholar
• Pastore G, Carli M, Memerle J. Epidemiological features of Wilms' tumor: Results of studies by the International Society of Paediatric Oncology (SIOP). Med Pediatr Oncol 1988; 16: 7–11
   PubMedGoogle Scholar
• Knudson AG, Strong LC. Mutation and cancer: a model for Wilms' tumor of the kidney. J Natl Cancer Inst 1972; 48: 313–324
   PubMed Web of Science ®Google Scholar
• Bove KE, Koffler H, McAdams J. Nodular renal blastema, definition and possible significance. Cancer 1969; 24: 323–332
   PubMed Web of Science ®Google Scholar
• Beckwith JB, Kiviat NB, Bonadio JF. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol 1990; 10: 1–36
   PubMedGoogle Scholar
• Fine H. The development of the lobes of the metanephros and fetal kidney. Acta Anat 1982; 113: 93–107
   PubMedGoogle Scholar
• Riccardi VM, Sujansky E, Smith AC. Chromosomal imbalance in the aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics 1978; 61: 604–610
   PubMed Web of Science ®Google Scholar
• Francke U, Holmes LB, Atkins L. Aniridia-Wilms' tumor association: Evidence for specific deletion of 11p13. Cytogenet Cell Genet 1979; 24: 185–192
   PubMedGoogle Scholar
• Van Heyningen V, Boyd PA, Seawright A. Molecular analysis of chromosome 11 deletions in aniridia-Wilms' tumor syndrome. Proc Natl Acad Sci USA 1985; 82: 8592–8596
   PubMed Web of Science ®Google Scholar
• Glaser T, Lewis WH, Bruns GA. The B-subunit of folliclestimulating hormone is deleted in patients with aniridia and Wilms' tumor allowing further definition of the WAGR locus. Nature 1986; 321: 882–887
   PubMed Web of Science ®Google Scholar
• Porteous DT, Bickmore W, Christie S. HRAS 1 selected chromosome transfer generates markers that colocalize aniridiaand genitourinary dysplasia-associated translocation breakpoints and the Wilms' tumor gene within 11p13. Proc Natl Acad Sci USA 1987; 84: 5355–5359
   PubMed Web of Science ®Google Scholar
• Davis LM, Byers MG, Fukushima Y. Four new DNA markers are assigned to the WAGR region of 11p13: Isolation and regional assignments of 112 chromosome 11 anonymous DNA segments. Genomics 1988; 3: 264–272
   PubMed Web of Science ®Google Scholar
• Bickmore WA, Porteous DJ, Christie S. CpG islands surround a DNA segment located between translocation breakpoints associated with genitourinary dysplasia and aniridia. Genomics 1989; 5: 685–693
   PubMed Web of Science ®Google Scholar
• Compton DA, Weil MM, Bonetta L. Definition of the limits of the Wilms' tumor locus on human chromosome 11p13. Genomics 1990; 6: 309–315
   PubMed Web of Science ®Google Scholar
• Rose EA, Glasser T, Jones C. Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene. Cell 1990; 60: 495–508
   PubMed Web of Science ®Google Scholar
• Slater RM, Mannens M. Cytogenetics and molecular genetics of Wilms' tumor of childhood. Cancer Genet Cytogenet 1992; 61: 111–121
   PubMed Web of Science ®Google Scholar
• Koufos A, Hansen MF, Lampkin BC. Loss of alleles on human chromosome 11 during genesis of Wilms' tumour. Nature 1984; 309: 170–172
   PubMed Web of Science ®Google Scholar
• Orkin SH, Goldman DS, Sallan SE. Development of homozygosity for chromosome 11p markers in Wilms' tumour. Nature 1984; 309: 172–174
   PubMed Web of Science ®Google Scholar
• Reeve AE, Housiaux PJ, Gardner RJ. Loss of a Harvey ras allele in sporadic Wilms' tumour. Nature 1984; 309: 174–176
   PubMed Web of Science ®Google Scholar
• Fearon E, Vogelstein B, Feinberg A. Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumors. Nature 1984; 309: 176–178
   PubMed Web of Science ®Google Scholar
• Glaser T, Jones C, Call KM. Mapping the WAGR region of chromosome 11p: Somatic cell hybrids provide a fine structure map. Cytogenet Cell Genet 1987; 46: 620
   Google Scholar
• Gessler M, Bruns GA. A physical map around the WAGR complex on the short arm of chromosome 11. Genomics 1989; 5: 43–55
   PubMed Web of Science ®Google Scholar
• Compton DA, Weil MM, Jones C. Long range physical map of the Wilms' tumor-aniridia region on human chromosome 11. Cell 1988; 55: 827–836
   PubMed Web of Science ®Google Scholar
• Davis LM, Stallard R, Thomas GH. Two anonymous DNA segments distinguish the Wilms' tumor and aniridia loci. Science 1988; 241: 840–842
   PubMed Web of Science ®Google Scholar
• Gessler M, Simola K OJ, Bruns G AP. Cloning of the breakpoints of a chromosome translocation identifies the AN2 locus. Science 1989; 244: 1575–1578
   PubMed Web of Science ®Google Scholar
• Call KM, Glaser T, Ito CY. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990; 60: 509–520
   PubMed Web of Science ®Google Scholar
• Gessler M, Poustka A, Cavenee W. Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature 1990; 343: 774–778
   PubMed Web of Science ®Google Scholar
• Bonetta L, Kuehn SE, Huang A. Wilms' tumor locus on 11p13 defined by multiple CpG island-associated transcripts. Science 1990; 250: 994–997
   PubMed Web of Science ®Google Scholar
• Haber DA, Sohn RL, Buckler AJ. Alternative splicing and genomic structure of the Wilms' tumor gene WT1. Proc Natl Acad Sci USA 1991; 88: 9618–9622
   PubMed Web of Science ®Google Scholar
• Brenner B, Wildhardt G, Schneider S. RNA polymerase chain reaction detects different levels of four alternatively spliced WT1 transcripts in Wilm's tumors. Oncogene 1992; 7: 1431–1433
   PubMed Web of Science ®Google Scholar
• Morris JF, Madden SL, Tournay OE. Characterization of the zinc finger protein encoded by the WT1 Wilm's tumor locus. Oncogene 1991; 6: 2339–2348
   PubMed Web of Science ®Google Scholar
• Telerman A, Dodemont H, Degraef C. Identification of the cellular protein encoded by the human Wilm's tumor (WT1) gene. Oncogene 1992; 7: 2545–2548
   PubMed Web of Science ®Google Scholar
• Evans B, Hollenberg S. Zinc fingers: Gilt by association. Cell 1988; 52: 1–3
   PubMed Web of Science ®Google Scholar
• Joseph LJ, LeBeau MM, Jamieson GA. Molecular cloning, sequencing and mapping of EGR2, a human early growth response gene encoding a protein with zinc-binding finger structure. Proc Natl Acad Sci USA 1988; 85: 7164–7168
   PubMed Web of Science ®Google Scholar
• Sukhatime VP, Cao X, Chang LC. A zinc finger encoding gene coregulated with c-fox during growth and differentiation and after cellular depolarization. Cell 1988; 53: 37–43
   PubMed Web of Science ®Google Scholar
• Rauscher FJ, Morris JF, Tournay OE. Binding of the Wilms' tumor locus zinc finger protein to the EGR1 consensus sequence. Science 1990; 250: 1259–1262
   PubMed Web of Science ®Google Scholar
• Mitchell PJ, Tijan T. Transcriptional regulation in mammalian cells by sequence specific DNA binding proteins. Science 1989; 24: 371–378
   Google Scholar
• Madden SC, Cook DM, Morris JF. Transcriptional repression mediated by the WT1 Wilms' tumor gene product. Science 1991; 253: 1550–1553
   PubMed Web of Science ®Google Scholar
• Bickmore WA, Oghene K, Little MH. Modulation of DNA binding specificity by alternative splicing of the Wilm's tumor WT1 gene transcript. Science 1992; 257: 235–237
   PubMed Web of Science ®Google Scholar
• Gashler AL, Bonthron DT, Madden SL. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms' tumor suppressor WT1. Proc Natl Acad Sci USA 1992; 89: 6010–6014
   PubMedGoogle Scholar
• Drummond IA, Madden SL, Rohwer-Nutter P. Repression of the insulin-like growth factor 11 gene by the Wilms' tumor suppressor WT1. Science 1992; 257: 674–678
   PubMed Web of Science ®Google Scholar
• Pritchard-Jones K, Fleming S, Davidson D. The candidate Wilms' tumour gene is involved in genitourinary development. Nature 1990; 346: 194–197
   PubMed Web of Science ®Google Scholar
• Pritchard-Jones K, Fleming S. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumor: Implications for tumour histogenesis. Oncogene 1991; 6: 2211–2220
   PubMed Web of Science ®Google Scholar
• Gerald WL, Gramling S, Sens DA. Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor. Am J Pathol 1992; 140: 1031–1037
   PubMed Web of Science ®Google Scholar
• Miwa H, Tomlinsom GE, Timmons CF. RNA expression of the WT1 gene in Wilms' tumors in relation to histology. J Natl Cancer Inst 1992; 84: 181–187
   PubMed Web of Science ®Google Scholar
• Yeger H, Cullinane C, Flenniken A. Coordinate expression of Wilm's tumor genes correlates with Wilm's tumor pheno-types. Cell Growth Different 1992; 3: 855–864
   PubMedGoogle Scholar
• Lewis WH, Yeger H, Bonetta L. Homozygous deletion of a DNA marker from chromosome 11p13 in sporadic Wilms' tumor. Genomics 1988; 3: 25–31
   PubMedGoogle Scholar
• Sharma PM, Yang X, Bowman M. Molecular cloning of rat Wilms' tumor complementary DNA and a study of messenger RNA expression in the urogenital system and the brain. Cancer Res 1992; 52: 6407–6412
   PubMed Web of Science ®Google Scholar
• Royer-Pokora B, Raggs S, Heckl-Ostreicher B. Direct pulsed field gel electrophoresis of Wilms' tumors shows that DNA deletions in 11p13 are rare. Gene Chromosomes Cancer 1991; 3: 89–199
   PubMed Web of Science ®Google Scholar
• Haber DA, Buckler AJ, Glaser T. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 1990; 61: 1257–1269
   PubMed Web of Science ®Google Scholar
• Cowell JK, Wadey RB, Haber DA. Structural rearrangements of the WT1 gene in Wilms' tumor cells. Oncogene 1991; 6: 595–599
   PubMed Web of Science ®Google Scholar
• Ton C CT, Huff V, Call KM. Smallest region of overlap in Wilms' tumor deletions uniquely implicates an 11p13 zinc finger gene as the disease locus. Genomics 1991; 10: 293–297
   PubMed Web of Science ®Google Scholar
• Little MH, Prosser J, Condie A. Zinc finger point mutations within the WT1 gene in Wilms' tumor patients. Proc Natl Acad Sci USA 1992; 89: 4791–4795
   PubMed Web of Science ®Google Scholar
• Tadokoro K, Fujii H, Ohishima A. Intragenic homozygous deletion of the WT1 gene in Wilms' tumor. Oncogene 1992; 7: 1215–1221
   PubMed Web of Science ®Google Scholar
• Coppes MJ, Liefers GJ, Paul P. Homozygous somatic WT1 point mutations in sporadic unilateral Wilms' tumor. Proc Natl Acad Sci USA 1993; 90: 1416–1419
   PubMed Web of Science ®Google Scholar
• Huff V, Miwa H, Haber DA. Evidence for WT1 as a Wilms' tumor (WT) gene: Intragenic germinal deletion in bilateral WT. AM J Hum Genet 1991; 48: 997–1003
   PubMed Web of Science ®Google Scholar
• Pelletier J, Bruening W, Li FP. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumor. Nature 1991; 353: 431–434
   PubMed Web of Science ®Google Scholar
• Brown KW, Watson JE, Poirier V. Inactivation of the remaining allele of the WT1 gene in a Wilm's tumour from a WAGR patient. Oncogene 1992; 7: 763–768
   PubMed Web of Science ®Google Scholar
• Baird PN, Groves N, Haber DA. Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome. Oncogene 1992; 7: 2141–2149
   PubMed Web of Science ®Google Scholar
• Akasaka Y, Kikuchi H, Nagai T. A point mutation found in the WT1 gene in a sporadic Wilm's tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome. FEBS Lett 1993; 317: 39–43
   PubMed Web of Science ®Google Scholar
• Haber DA, Timmers HT, Pelletier J. A dominant mutation in the Wilms' tumor gene WT1 cooperates with the viral oncogene E1A in transformation of primary kidney cells. Proc Natl Acad Sci USA 1992; 89: 6010–6014
   PubMed Web of Science ®Google Scholar
• Mannens M, Slater RM, Heyting C. Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome II in Wilms' tumors. Hum Genet 1988; 81: 41–48
   PubMed Web of Science ®Google Scholar
• Schroeder WT, Chao LY, Dao DD. Non-random loss of maternal chromosome 11 alleles in Wilms' tumors. Am J Hum Genet 1987; 40: 413–420
   PubMed Web of Science ®Google Scholar
• Pal N, Wadey RB, Buckler B. Preferential loss of maternal alleles in sporadic Wilms' tumor. Oncogene 1990; 5: 1665–1668
   PubMed Web of Science ®Google Scholar
• Scrable H, Cavenee W, Ghavimi F. A model for embryonal rhabdomyosarcoma tumorigenesis that involves imprinting. Proc Natl Acad Sci USA 1989; 86: 7480–7484
   PubMed Web of Science ®Google Scholar
• Hall JG. Genomic imprinting: Review and relevance to human diseases. Am J Hum Genet 1990; 46: 857–873
   PubMed Web of Science ®Google Scholar
• Toguchida J, Ishizak K, Sasaki MS. Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. Nature 1988; 336: 377–378
   PubMedGoogle Scholar
• Rainier S, Johnson LA, Dobry CJ. Relaxation of imprinted genes in human cancer. Nature 1993; 362: 747–749
   PubMed Web of Science ®Google Scholar
• Ogawa O, Eccles MR, Szeto J. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilm's tumour. Nature 1993; 362: 749–751
   PubMed Web of Science ®Google Scholar
• Pelletier J, Bruening W, Kashtan CE. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991; 67: 437–447
   PubMed Web of Science ®Google Scholar
• Coppes MJ, Liefers GJ, Higuchi M. Inherited WT1 mutation in Denys-Drash syndrome. Cancer Res 1992; 52: 6125–6128
   PubMed Web of Science ®Google Scholar
• Eccles MR, Millow LJ, Wilkins RJ. Harvey-ras allele deletion detected by in situ hybridization to Wilms' tumor chromosomes. Hum Genet 1984; 67: 190–192
   PubMed Web of Science ®Google Scholar
• Koufos A, Grundy P, Morgan K. Familial Wiedemann-Beckwith syndrome and a second Wilms' tumor locus map to 11p15.5. Am J Hum Genet 1989; 44: 711–719
   PubMed Web of Science ®Google Scholar
• Dao DD, Schroeder WT, Chao LY. Genetic mechanisms of tumor specific loss of 11p DNA sequences in Wilms' tumor. Am J Hum Genet 1987; 41: 202–217
   PubMed Web of Science ®Google Scholar
• Reeve AE, Sih SA, Raizis AM. Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells. Mol Genet Biol 1989; 9: 1799–1803
   Web of Science ®Google Scholar
• Henry I, Jeanpierre M, Couillin P. Tumor-specific loss of 11p15.5 alleles in del 11p13 Wilms' tumor and in familial adrenocortical carcinoma. Proc Natl Acad Sci USA 1989; 86: 3247–3251
   PubMed Web of Science ®Google Scholar
• Waziri M, Patil S, Hanson J. Abnormality of chromosome 11 in patients with features of Beckwith-Wiedemann syndrome. J Pediatr 1983; 102: 873–876
   PubMed Web of Science ®Google Scholar
• Human Gene Mapping IO. Tenth international workshop on human gene mapping. Cytogenet Cell Genet 1989; 51: 1–4
   Google Scholar
• Mannens M, Devilee P, Bliek J. Loss of heterozygosity in Wilms' tumors, studied for six putative tumor-suppressor regions, is limited to chromosome 11. Cancer Res 1990; 50: 3279–3283
   PubMed Web of Science ®Google Scholar
• Wadey RB, Pal N, Buckle B. Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11. Oncogene 1990; 5: 901–907
   PubMed Web of Science ®Google Scholar
• Grundy P, Koufos A, Morgan K. Familial predisposition to Wilms' tumor does not map to the short arm of chromosome 11. Nature 1988; 336: 374–376
   PubMed Web of Science ®Google Scholar
• Huff V, Compton D, Chao L. Lack of linkage of familial Wilms' tumor to chromosomal band 11p13. Nature 1988; 336: 377–378
   PubMed Web of Science ®Google Scholar
• Schwartz CE, Haber DA, Stanton VP. Familial predisposition to Wilms' tumor does not segregate with WT1 gene. Genomics 1991; 10: 927–930
   PubMed Web of Science ®Google Scholar
• Maw MA, Grundy PE, Millow LJ. A third Wilms' tumor locus on chromosome 16q. Cancer Res 1992; 52: 3094–3098
   PubMed Web of Science ®Google Scholar
• Coppes MJ, Bonetta L, Huang A. Loss of heterozygosity mapping in Wilms' tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination. Genes Chromosomes Cancer 1992; 5: 326–334
   PubMed Web of Science ®Google Scholar
• Huff V, Reeve AE, Leppert M. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor. Cancer Res 1992; 52: 6117–6120
   PubMed Web of Science ®Google Scholar
• Lemoine NR, Hughes CM, Cowell JK. Aberrant expression of the tumour suppressor gene p53 is very frequent in Wilms' tumours. J Pathol 1992; 168: 237–242
   PubMed Web of Science ®Google Scholar
• Perantoni AO, Beckwith JB, Enomoto T. Activation of the K-ras oncogene occurs in high incidence in pediatric but not adult renal neoplasms. Abstract presented at the second meeting on the Molecular Basis of Human Cancer. 1991
   Google Scholar